Logo-jrip

Indexing Information

Scupos

 

Member of

Follower of





 

J Renal Inj Prev. 2018;7(4): 259-263. doi: 10.15171/jrip.2018.58

Original

Cystatin C as a biomarker of acute kidney injury in a group of critically ill children in a pediatric intensive care unit

Sepideh Bagheri 1, Mohammad Esmaeeli 1, Yalda Ravanshad 2,3 * , Anoush Azarfar 1, Aida Foroutan 1, Sahar Ravanshad 4, Hassan Mehrad-Majd 2, Anahita Alizadeh 5

Cited by CrossRef: 1

1- Magomedaliev M, Korabelnikov D. Cystatin C: factors affecting diagnostic and prognostic value in acute kidney injury. Farmakoèkonomika. 2024;17(3):376 [Crossref]
2- Vlodavets D, Artemyeva S, Glebovskaya O, Nakhusheva F, Ayzatulina D, Grankin E, Ipatova S, Shishkina E, Korotkova D, Zhivaeva O, Sayfullina E, Treskina G, Gukosyan D, Momot G, Tsyngunova L. Pathogenetic therapy for Duchenne muscular dystrophy: Russian experience with viltolarsen. Russian journal of child neurology. 2026;20(4):34 [Crossref]
3- Luna S, Bushra F, Sultana J, Sultana N, Mamun A, Huque S, Jesmin T, Begum A, Roy R. Role of Cystatin C for Early Detection of Acute Kidney Injury in Children. Paediatr Nephrol J Bangladesh. 2024;9(2):58 [Crossref]